GFAP and myeloid sarcoma: GFAP expression in EGC is increased under inflammatory stress and neuroinflammatory disorders, including MS (Wunsch et al. 2017) and GFAP-positive EGC have recently been proposed to possess neurogenic potential (Guyer et al. 2023).